Persistent intrathecal interleukin-8 production in a patient with SARS-CoV-2-related encephalopathy presenting aphasia: a case report.
Abstract Background Neurological manifestations of coronavirus disease 2019 (COVID-19) are increasingly recognized and include encephalopathy, although direct infection of the brain by SARS-CoV-2 remains controversial. We herein report the clinical course and cytokine profiles of a patient with seve...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ecfbcd3f50a24664b58b68b3b3283c17 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ecfbcd3f50a24664b58b68b3b3283c17 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ecfbcd3f50a24664b58b68b3b3283c172021-11-07T12:23:03ZPersistent intrathecal interleukin-8 production in a patient with SARS-CoV-2-related encephalopathy presenting aphasia: a case report.10.1186/s12883-021-02459-31471-2377https://doaj.org/article/ecfbcd3f50a24664b58b68b3b3283c172021-11-01T00:00:00Zhttps://doi.org/10.1186/s12883-021-02459-3https://doaj.org/toc/1471-2377Abstract Background Neurological manifestations of coronavirus disease 2019 (COVID-19) are increasingly recognized and include encephalopathy, although direct infection of the brain by SARS-CoV-2 remains controversial. We herein report the clinical course and cytokine profiles of a patient with severe SARS-CoV-2-related encephalopathy presenting aphasia. Case presentation An 81-year-old man developed acute consciousness disturbance and status epileptics several days after SARS-CoV-2 infection. Following treatment with remdesivir and dexamethasone, his consciousness and epileptic seizures improved; however, amnestic aphasia and agraphia remained. Two months after methylprednisolone pulse and intravenous immunoglobulin, his neurological deficits improved. We found increased levels of interleukin (IL)-6, IL-8, and monocyte chemoattractant protein-1 (MCP-1), but not IL-2 and IL-10 in the serum and cerebrospinal fluid (CSF), and the levels of serum IL-6 and MCP-1 were much higher than those in the CSF. The level of IL-8 in the CSF after immunotherapy was four times higher than that before immunotherapy. Conclusion The cytokine profile of our patient was similar to that seen in severe SARS-CoV-2-related encephalopathy. We demonstrated (i) that the characteristic aphasia can occur as a focal neurological deficit associated with SARS-CoV-2-related encephalopathy, and (ii) that IL8-mediated central nervous system inflammation follows systemic inflammation in SARS-CoV-2-related encephalopathy and can persist and worsen even after immunotherapy. Monitoring IL-8 in CSF, and long-term corticosteroids may be required for treating SARS-CoV-2-related encephalopathy.Takuya KudoYuichi HayashiKenjiro KuniedaNobuaki YoshikuraAkio KimuraMika OtsukiTakayoshi ShimohataBMCarticleSARS-CoV-2EncephalopathyIL-8AphasiaCase reportNeurology. Diseases of the nervous systemRC346-429ENBMC Neurology, Vol 21, Iss 1, Pp 1-4 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
SARS-CoV-2 Encephalopathy IL-8 Aphasia Case report Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
SARS-CoV-2 Encephalopathy IL-8 Aphasia Case report Neurology. Diseases of the nervous system RC346-429 Takuya Kudo Yuichi Hayashi Kenjiro Kunieda Nobuaki Yoshikura Akio Kimura Mika Otsuki Takayoshi Shimohata Persistent intrathecal interleukin-8 production in a patient with SARS-CoV-2-related encephalopathy presenting aphasia: a case report. |
description |
Abstract Background Neurological manifestations of coronavirus disease 2019 (COVID-19) are increasingly recognized and include encephalopathy, although direct infection of the brain by SARS-CoV-2 remains controversial. We herein report the clinical course and cytokine profiles of a patient with severe SARS-CoV-2-related encephalopathy presenting aphasia. Case presentation An 81-year-old man developed acute consciousness disturbance and status epileptics several days after SARS-CoV-2 infection. Following treatment with remdesivir and dexamethasone, his consciousness and epileptic seizures improved; however, amnestic aphasia and agraphia remained. Two months after methylprednisolone pulse and intravenous immunoglobulin, his neurological deficits improved. We found increased levels of interleukin (IL)-6, IL-8, and monocyte chemoattractant protein-1 (MCP-1), but not IL-2 and IL-10 in the serum and cerebrospinal fluid (CSF), and the levels of serum IL-6 and MCP-1 were much higher than those in the CSF. The level of IL-8 in the CSF after immunotherapy was four times higher than that before immunotherapy. Conclusion The cytokine profile of our patient was similar to that seen in severe SARS-CoV-2-related encephalopathy. We demonstrated (i) that the characteristic aphasia can occur as a focal neurological deficit associated with SARS-CoV-2-related encephalopathy, and (ii) that IL8-mediated central nervous system inflammation follows systemic inflammation in SARS-CoV-2-related encephalopathy and can persist and worsen even after immunotherapy. Monitoring IL-8 in CSF, and long-term corticosteroids may be required for treating SARS-CoV-2-related encephalopathy. |
format |
article |
author |
Takuya Kudo Yuichi Hayashi Kenjiro Kunieda Nobuaki Yoshikura Akio Kimura Mika Otsuki Takayoshi Shimohata |
author_facet |
Takuya Kudo Yuichi Hayashi Kenjiro Kunieda Nobuaki Yoshikura Akio Kimura Mika Otsuki Takayoshi Shimohata |
author_sort |
Takuya Kudo |
title |
Persistent intrathecal interleukin-8 production in a patient with SARS-CoV-2-related encephalopathy presenting aphasia: a case report. |
title_short |
Persistent intrathecal interleukin-8 production in a patient with SARS-CoV-2-related encephalopathy presenting aphasia: a case report. |
title_full |
Persistent intrathecal interleukin-8 production in a patient with SARS-CoV-2-related encephalopathy presenting aphasia: a case report. |
title_fullStr |
Persistent intrathecal interleukin-8 production in a patient with SARS-CoV-2-related encephalopathy presenting aphasia: a case report. |
title_full_unstemmed |
Persistent intrathecal interleukin-8 production in a patient with SARS-CoV-2-related encephalopathy presenting aphasia: a case report. |
title_sort |
persistent intrathecal interleukin-8 production in a patient with sars-cov-2-related encephalopathy presenting aphasia: a case report. |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/ecfbcd3f50a24664b58b68b3b3283c17 |
work_keys_str_mv |
AT takuyakudo persistentintrathecalinterleukin8productioninapatientwithsarscov2relatedencephalopathypresentingaphasiaacasereport AT yuichihayashi persistentintrathecalinterleukin8productioninapatientwithsarscov2relatedencephalopathypresentingaphasiaacasereport AT kenjirokunieda persistentintrathecalinterleukin8productioninapatientwithsarscov2relatedencephalopathypresentingaphasiaacasereport AT nobuakiyoshikura persistentintrathecalinterleukin8productioninapatientwithsarscov2relatedencephalopathypresentingaphasiaacasereport AT akiokimura persistentintrathecalinterleukin8productioninapatientwithsarscov2relatedencephalopathypresentingaphasiaacasereport AT mikaotsuki persistentintrathecalinterleukin8productioninapatientwithsarscov2relatedencephalopathypresentingaphasiaacasereport AT takayoshishimohata persistentintrathecalinterleukin8productioninapatientwithsarscov2relatedencephalopathypresentingaphasiaacasereport |
_version_ |
1718443522894331904 |